Implementation of an Oral Chemotherapy Adherence Intervention

Launched by UNC LINEBERGER COMPREHENSIVE CANCER CENTER · May 16, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new program designed to help patients better stick to their oral cancer medications. The goal is to see how effective this program is in improving medication adherence, which means taking the prescribed medications correctly and on time. The study will involve 160 adults with solid tumors or blood cancers (hematologic malignancies) who have been taking their oral cancer medications for at least six months. Participants will be divided into two groups: one group will answer questions about their medication habits before the program starts, and the other group will answer the same questions after being part of the program for six months.

To be eligible for this study, participants need to be at least 21 years old and currently undergoing treatment for their cancer with a single oral medication for at least six months. However, those on short-term treatments or receiving end-of-life care cannot participate. If you join this trial, you can expect to fill out surveys that help researchers understand how well the program works in helping people remember to take their medications. The findings from this study could lead to better support for cancer patients in managing their treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult (age ≥21 years-old) patients
• • Diagnosed with a solid or hematologic malignancy
• • Monotherapy on oral anticancer agent on treatment for at least 6 months
• Exclusion criteria:
• • Patients on time-limited or intermittent therapy (non-continuous)
• • Patients on comfort (end-of-life) care
• • Patients enrolled on hospice